Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-12-07

AUTHORS

Takuya Takeichi, Masashi Akiyama

ABSTRACT

Generalized pustular psoriasis (GPP) is a chronic, systemic inflammatory disease accompanied by high fever and general malaise. Diffuse erythema and swelling of the extremities occur, with multiple sterile pustules all over the body in GPP patients. GPP often relapses over the lifetime and can be life-threatening. Recent discoveries of the underlying molecular genetic basis of many cases of this disorder have provided major advances to clinicians and researchers towards an understanding of the pathomechanism of GPP. However, the therapeutic management of GPP still faces many challenges and much uncertainty, and an evidence-based review summarizing the available clinical data on the management of this heterogeneous disease is needed. The present review addresses challenges regarding the precise clinical diagnosis and evaluation of clinical symptoms in GPP. In addition, we update and briefly summarize the current understanding of molecular pathomechanisms behind GPP as an autoinflammatory keratinization disease. Recent publications have clarified the genetic backgrounds of patients with GPP and ethnic differences in predisposing factors. Although there are ethnic differences in the prevalences of these pathogenic alleles, from recent reports, at most 60.5% (IL36RN), 5.9% (CARD14), and 10.8% (AP1S3) of GPP patients have the mutations/variations of these genes. All the reported biologics studied seemed effective and relatively well tolerated. Although it is difficult to evaluate therapeutic efficacy from studies on just a few cases, recent findings suggest that biologics can be a useful, powerful tool for controlling skin and systemic inflammation in GPP and for improving the quality of life of GPP patients. More... »

PAGES

227-236

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40257-019-00492-0

DOI

http://dx.doi.org/10.1007/s40257-019-00492-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1123215774

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31813117


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Products", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CARD Signaling Adaptor Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diagnosis, Differential", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guanylate Cyclase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Psoriasis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takeichi", 
        "givenName": "Takuya", 
        "id": "sg:person.01060264162.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060264162.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Akiyama", 
        "givenName": "Masashi", 
        "id": "sg:person.013324706103.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013324706103.19"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00439-016-1750-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001460596", 
          "https://doi.org/10.1007/s00439-016-1750-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11586900-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051128174", 
          "https://doi.org/10.2165/11586900-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00403-002-0371-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075264074", 
          "https://doi.org/10.1007/s00403-002-0371-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12-07", 
    "datePublishedReg": "2019-12-07", 
    "description": "Generalized pustular psoriasis (GPP) is a chronic, systemic inflammatory disease accompanied by high fever and general malaise. Diffuse erythema and swelling of the extremities occur, with multiple sterile pustules all over the body in GPP patients. GPP often relapses over the lifetime and can be life-threatening. Recent discoveries of the underlying molecular genetic basis of many cases of this disorder have provided major advances to clinicians and researchers towards an understanding of the pathomechanism of GPP. However, the therapeutic management of GPP still faces many challenges and much uncertainty, and an evidence-based review summarizing the available clinical data on the management of this heterogeneous disease is needed. The present review addresses challenges regarding the precise clinical diagnosis and evaluation of clinical symptoms in GPP. In addition, we update and briefly summarize the current understanding of molecular pathomechanisms behind GPP as an autoinflammatory keratinization disease. Recent publications have clarified the genetic backgrounds of patients with GPP and ethnic differences in predisposing factors. Although there are ethnic differences in the prevalences of these pathogenic alleles, from recent reports, at most 60.5% (IL36RN), 5.9% (CARD14), and 10.8% (AP1S3) of GPP patients have the mutations/variations of these genes. All the reported biologics studied seemed effective and relatively well tolerated. Although it is difficult to evaluate therapeutic efficacy from studies on just a few cases, recent findings suggest that biologics can be a useful, powerful tool for controlling skin and systemic inflammation in GPP and for improving the quality of life of GPP patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40257-019-00492-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7542888", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1021743", 
        "issn": [
          "1175-0561", 
          "1179-1888"
        ], 
        "name": "American Journal of Clinical Dermatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "GPP patients", 
      "autoinflammatory keratinization diseases", 
      "systemic inflammatory disease", 
      "available clinical data", 
      "evidence-based review", 
      "ethnic differences", 
      "quality of life", 
      "precise clinical diagnosis", 
      "sterile pustules", 
      "systemic inflammation", 
      "pustular psoriasis", 
      "high fever", 
      "clinical symptoms", 
      "general malaise", 
      "therapeutic management", 
      "diffuse erythema", 
      "inflammatory diseases", 
      "clinical management", 
      "clinical data", 
      "heterogeneous disease", 
      "therapeutic efficacy", 
      "patients", 
      "clinical diagnosis", 
      "molecular pathomechanisms", 
      "disease", 
      "pathogenic alleles", 
      "mutations/variations", 
      "pathomechanism", 
      "recent reports", 
      "present review", 
      "biologics", 
      "recent findings", 
      "major advances", 
      "genetic background", 
      "molecular genetic basis", 
      "current understanding", 
      "psoriasis", 
      "erythema", 
      "review", 
      "inflammation", 
      "fever", 
      "management", 
      "symptoms", 
      "clinicians", 
      "prevalence", 
      "extremities", 
      "recent publications", 
      "diagnosis", 
      "malaise", 
      "disorders", 
      "efficacy", 
      "pustules", 
      "skin", 
      "recent discovery", 
      "differences", 
      "genetic basis", 
      "cases", 
      "report", 
      "swelling", 
      "findings", 
      "alleles", 
      "factors", 
      "evaluation", 
      "study", 
      "life", 
      "genes", 
      "background", 
      "update", 
      "body", 
      "challenges", 
      "understanding", 
      "advances", 
      "addition", 
      "data", 
      "publications", 
      "quality", 
      "discovery", 
      "GPP", 
      "powerful tool", 
      "aspects", 
      "tool", 
      "basis", 
      "variation", 
      "researchers", 
      "lifetime", 
      "uncertainty", 
      "multiple sterile pustules", 
      "pathomechanism of GPP", 
      "keratinization disease", 
      "Autoinflammatory Aspects"
    ], 
    "name": "Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects", 
    "pagination": "227-236", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1123215774"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40257-019-00492-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31813117"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40257-019-00492-0", 
      "https://app.dimensions.ai/details/publication/pub.1123215774"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_831.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40257-019-00492-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40257-019-00492-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40257-019-00492-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40257-019-00492-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40257-019-00492-0'


 

This table displays all metadata directly associated to this object as RDF triples.

209 TRIPLES      22 PREDICATES      128 URIs      117 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40257-019-00492-0 schema:about N036ccaffaea94cea9fe9850eae168c6a
2 N1f32ded6bc1c4813ab598fb87e7ef8ca
3 N2821eb05f7a446b684fd2554c70cae02
4 N30865079d1fc4ebf8e421871aedf5323
5 N5bb3595257d84a89a7a1c2712a115532
6 N672e78f3a0f741f98f66146f4d5a69bc
7 N6b710b08831547a88b9cfe3baefbd998
8 N6fe33b1d27ba4ef88a834ba0479b8245
9 Nfd80ba82f5e3413f9c7aa4e18290a8da
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author N82081e2427744c00a39379766e92a0be
13 schema:citation sg:pub.10.1007/s00403-002-0371-6
14 sg:pub.10.1007/s00439-016-1750-y
15 sg:pub.10.2165/11586900-000000000-00000
16 schema:datePublished 2019-12-07
17 schema:datePublishedReg 2019-12-07
18 schema:description Generalized pustular psoriasis (GPP) is a chronic, systemic inflammatory disease accompanied by high fever and general malaise. Diffuse erythema and swelling of the extremities occur, with multiple sterile pustules all over the body in GPP patients. GPP often relapses over the lifetime and can be life-threatening. Recent discoveries of the underlying molecular genetic basis of many cases of this disorder have provided major advances to clinicians and researchers towards an understanding of the pathomechanism of GPP. However, the therapeutic management of GPP still faces many challenges and much uncertainty, and an evidence-based review summarizing the available clinical data on the management of this heterogeneous disease is needed. The present review addresses challenges regarding the precise clinical diagnosis and evaluation of clinical symptoms in GPP. In addition, we update and briefly summarize the current understanding of molecular pathomechanisms behind GPP as an autoinflammatory keratinization disease. Recent publications have clarified the genetic backgrounds of patients with GPP and ethnic differences in predisposing factors. Although there are ethnic differences in the prevalences of these pathogenic alleles, from recent reports, at most 60.5% (IL36RN), 5.9% (CARD14), and 10.8% (AP1S3) of GPP patients have the mutations/variations of these genes. All the reported biologics studied seemed effective and relatively well tolerated. Although it is difficult to evaluate therapeutic efficacy from studies on just a few cases, recent findings suggest that biologics can be a useful, powerful tool for controlling skin and systemic inflammation in GPP and for improving the quality of life of GPP patients.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N157c931151ae42e29aec0252b95eb3bb
23 Ne1591d13d572462fa656e9fb20aa5881
24 sg:journal.1021743
25 schema:keywords Autoinflammatory Aspects
26 GPP
27 GPP patients
28 addition
29 advances
30 alleles
31 aspects
32 autoinflammatory keratinization diseases
33 available clinical data
34 background
35 basis
36 biologics
37 body
38 cases
39 challenges
40 clinical data
41 clinical diagnosis
42 clinical management
43 clinical symptoms
44 clinicians
45 current understanding
46 data
47 diagnosis
48 differences
49 diffuse erythema
50 discovery
51 disease
52 disorders
53 efficacy
54 erythema
55 ethnic differences
56 evaluation
57 evidence-based review
58 extremities
59 factors
60 fever
61 findings
62 general malaise
63 genes
64 genetic background
65 genetic basis
66 heterogeneous disease
67 high fever
68 inflammation
69 inflammatory diseases
70 keratinization disease
71 life
72 lifetime
73 major advances
74 malaise
75 management
76 molecular genetic basis
77 molecular pathomechanisms
78 multiple sterile pustules
79 mutations/variations
80 pathogenic alleles
81 pathomechanism
82 pathomechanism of GPP
83 patients
84 powerful tool
85 precise clinical diagnosis
86 present review
87 prevalence
88 psoriasis
89 publications
90 pustular psoriasis
91 pustules
92 quality
93 quality of life
94 recent discovery
95 recent findings
96 recent publications
97 recent reports
98 report
99 researchers
100 review
101 skin
102 sterile pustules
103 study
104 swelling
105 symptoms
106 systemic inflammation
107 systemic inflammatory disease
108 therapeutic efficacy
109 therapeutic management
110 tool
111 uncertainty
112 understanding
113 update
114 variation
115 schema:name Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects
116 schema:pagination 227-236
117 schema:productId N1e8dacb5504049868c77f411bf16dbe3
118 Na5559822735144aaa206a2caa5e390d1
119 Nfd8a1a9a76d7474e8aa256560582e98a
120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1123215774
121 https://doi.org/10.1007/s40257-019-00492-0
122 schema:sdDatePublished 2022-01-01T18:54
123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
124 schema:sdPublisher N97e3c43841b646d18a1d0bffec95978c
125 schema:url https://doi.org/10.1007/s40257-019-00492-0
126 sgo:license sg:explorer/license/
127 sgo:sdDataset articles
128 rdf:type schema:ScholarlyArticle
129 N036ccaffaea94cea9fe9850eae168c6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Comorbidity
131 rdf:type schema:DefinedTerm
132 N157c931151ae42e29aec0252b95eb3bb schema:volumeNumber 21
133 rdf:type schema:PublicationVolume
134 N1e8dacb5504049868c77f411bf16dbe3 schema:name dimensions_id
135 schema:value pub.1123215774
136 rdf:type schema:PropertyValue
137 N1f32ded6bc1c4813ab598fb87e7ef8ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Interleukins
139 rdf:type schema:DefinedTerm
140 N2821eb05f7a446b684fd2554c70cae02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Biological Products
142 rdf:type schema:DefinedTerm
143 N30865079d1fc4ebf8e421871aedf5323 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name CARD Signaling Adaptor Proteins
145 rdf:type schema:DefinedTerm
146 N5bb3595257d84a89a7a1c2712a115532 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Membrane Proteins
148 rdf:type schema:DefinedTerm
149 N672e78f3a0f741f98f66146f4d5a69bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Guanylate Cyclase
151 rdf:type schema:DefinedTerm
152 N6b710b08831547a88b9cfe3baefbd998 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Psoriasis
154 rdf:type schema:DefinedTerm
155 N6fe33b1d27ba4ef88a834ba0479b8245 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Diagnosis, Differential
157 rdf:type schema:DefinedTerm
158 N82081e2427744c00a39379766e92a0be rdf:first sg:person.01060264162.15
159 rdf:rest N93b10ca7ea9342408736bfb0d368dd0a
160 N93b10ca7ea9342408736bfb0d368dd0a rdf:first sg:person.013324706103.19
161 rdf:rest rdf:nil
162 N97e3c43841b646d18a1d0bffec95978c schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 Na5559822735144aaa206a2caa5e390d1 schema:name pubmed_id
165 schema:value 31813117
166 rdf:type schema:PropertyValue
167 Ne1591d13d572462fa656e9fb20aa5881 schema:issueNumber 2
168 rdf:type schema:PublicationIssue
169 Nfd80ba82f5e3413f9c7aa4e18290a8da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Humans
171 rdf:type schema:DefinedTerm
172 Nfd8a1a9a76d7474e8aa256560582e98a schema:name doi
173 schema:value 10.1007/s40257-019-00492-0
174 rdf:type schema:PropertyValue
175 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
176 schema:name Medical and Health Sciences
177 rdf:type schema:DefinedTerm
178 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
179 schema:name Clinical Sciences
180 rdf:type schema:DefinedTerm
181 sg:grant.7542888 http://pending.schema.org/fundedItem sg:pub.10.1007/s40257-019-00492-0
182 rdf:type schema:MonetaryGrant
183 sg:journal.1021743 schema:issn 1175-0561
184 1179-1888
185 schema:name American Journal of Clinical Dermatology
186 schema:publisher Springer Nature
187 rdf:type schema:Periodical
188 sg:person.01060264162.15 schema:affiliation grid-institutes:grid.27476.30
189 schema:familyName Takeichi
190 schema:givenName Takuya
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060264162.15
192 rdf:type schema:Person
193 sg:person.013324706103.19 schema:affiliation grid-institutes:grid.27476.30
194 schema:familyName Akiyama
195 schema:givenName Masashi
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013324706103.19
197 rdf:type schema:Person
198 sg:pub.10.1007/s00403-002-0371-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075264074
199 https://doi.org/10.1007/s00403-002-0371-6
200 rdf:type schema:CreativeWork
201 sg:pub.10.1007/s00439-016-1750-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1001460596
202 https://doi.org/10.1007/s00439-016-1750-y
203 rdf:type schema:CreativeWork
204 sg:pub.10.2165/11586900-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051128174
205 https://doi.org/10.2165/11586900-000000000-00000
206 rdf:type schema:CreativeWork
207 grid-institutes:grid.27476.30 schema:alternateName Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan
208 schema:name Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan
209 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...